• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LTP
Click for more information
3.11% $1.72

LTR PHARMA LIMITED

Market Cap $145.4M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction (ED). Its lead product SPONTAN is set apart from existing ED therapies by its mechanism of action-intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less. SPONTAN (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
LTP
Valuation
2
20/09/24 61 25K
20/09/24 Last post  The Stripester Comments Created with Sketch.  61  Views Created with Sketch.  25K 
LTP
LTP Chart 		20/09/24 2 1.2K
20/09/24 Last post  insected Comments Created with Sketch.  2  Views Created with Sketch.  1.2K 
LTP
Spontan - I used it!
2
12/09/24 73 32K
12/09/24 Last post  Director12 Comments Created with Sketch.  73  Views Created with Sketch.  32K 
LTP
Next stop $2-00 + 		10/09/24 0 418
10/09/24 Last post  whatsup Comments Created with Sketch.  0  Views Created with Sketch.  418 
LTP
Ann: Investor Presentation 		06/09/24 8 5.8K
06/09/24 Last post  whatsup Comments Created with Sketch.  8  Views Created with Sketch.  5.8K 
LTP
Ann: LTR Pharma to List on the ASX
2 3
05/09/24 146 55K
05/09/24 Last post  whatsup Comments Created with Sketch.  146  Views Created with Sketch.  55K 
LTP
IPO - LTR Pharma Ltd - 11 December 2023 #
2 3
04/09/24 143 55K
04/09/24 Last post  chuk Comments Created with Sketch.  143  Views Created with Sketch.  55K 
LTP
Spontan - The party drug of 2025 		02/09/24 2 1.3K
02/09/24 Last post  Rustybullet1 Comments Created with Sketch.  2  Views Created with Sketch.  1.3K 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 4G and Corporate Governance Statement
30 Aug 09:29
 
FY24 Results Announcement
30 Aug 09:29
 
Appendix 4E and Annual Financial Report
30 Aug 09:27
 
SPONTAN Prescribed to First Patient by Authorised Prescriber
16 Aug 09:05
 
LTP Secures Global CoDevelopment Agreement with Aptar Pharma
13 Aug 09:17
 
Mens Health Expert Prescribes SPONTAN
08 Aug 09:16
 
View More arrow Created with Sketch.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
(20min delay)
Last
$1.72 		Change
-0.055(3.11%) 		Mkt cap ! $145.4M
Open High Low Value Volume
$1.77 $1.83 $1.69 $756.3K 432.5K

Buyers (Bids)

No. Vol. Price($)
1 1500 $1.71
 

Sellers (Offers)

Price($) Vol. No.
$1.72 1446 1
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
Last
$1.72 		  Change
-0.055 ( 2.54 %)
Open High Low Volume
$1.77 $1.81 $1.70 68593
Last updated 15.54pm 20/09/2024 ?
LTP (ASX) Chart

Top Stories

ASX Market Open: Aussie stocks follow US surge after Fed rate cut decision | September 20, 2024

Australia's stock market is set to open higher today, following record performances on Wall Street, following the Federal Reserve's rate cut
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Tennant Minerals clocks high-grade gold, copper hits at Bluebird in the NT Tennant Minerals has unveiled the results of its latest drill campaign at its Bluebird project, posting "high-grade" copper and gold hits.
Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025 Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.